Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Yan

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
Journal of the American Heart Association|May 10, 2017
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) IIIKit N Simpson, Annie N Simpson, Patrick D Mauldin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.
Annals of Neurology|February 20, 2022
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT StudiesAmrou Sarraj, Mark Parsons, Andrew Bivard, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 8, 2025
Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access)Ahmed Nasreldein, Wan Asyraf, Thanh N Nguyen, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
JAMA|February 7, 2024
Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-AnalysisJohannes Kaesmacher, Fabiano Cavalcante, Manon Kappelhof, et al.
Annals of Neurology|April 24, 2026
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel OcclusionChangwei Guo, Fabiano Cavalcante, Shihai Yang, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
The New England Journal of Medicine|February 9, 2013
Endovascular therapy after intravenous t-PA versus t-PA alone for strokeJoseph P Broderick, Yuko Y Palesch, Andrew M Demchuk, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
Journal of the American Heart Association|May 10, 2017
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) IIIKit N Simpson, Annie N Simpson, Patrick D Mauldin, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.
Annals of Neurology|February 20, 2022
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT StudiesAmrou Sarraj, Mark Parsons, Andrew Bivard, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 8, 2025
Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access)Ahmed Nasreldein, Wan Asyraf, Thanh N Nguyen, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|February 21, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than ThrombolysisHenry Zhao, Skye Coote, Damien Easton, et al.
JAMA|February 7, 2024
Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-AnalysisJohannes Kaesmacher, Fabiano Cavalcante, Manon Kappelhof, et al.
Annals of Neurology|April 24, 2026
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel OcclusionChangwei Guo, Fabiano Cavalcante, Shihai Yang, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
The New England Journal of Medicine|February 9, 2013
Endovascular therapy after intravenous t-PA versus t-PA alone for strokeJoseph P Broderick, Yuko Y Palesch, Andrew M Demchuk, et al.
Pageof 27